280 related articles for article (PubMed ID: 21566302)
21. A comparison of combinations of diuretics in nephrotic edema.
Garin EH
Am J Dis Child; 1987 Jul; 141(7):769-71. PubMed ID: 3296741
[TBL] [Abstract][Full Text] [Related]
22. Intratubular albumin blunts the response to furosemide-A mechanism for diuretic resistance in the nephrotic syndrome.
Kirchner KA; Voelker JR; Brater DC
J Pharmacol Exp Ther; 1990 Mar; 252(3):1097-101. PubMed ID: 2319462
[TBL] [Abstract][Full Text] [Related]
23. [Effect of dextran combination with flurosemide on nephrotic syndrome].
Chen X; Liu H; Ma ZH
Hunan Yi Ke Da Xue Xue Bao; 2001 Aug; 26(4):374-6. PubMed ID: 12536743
[TBL] [Abstract][Full Text] [Related]
24. Renal effects of conivaptan, furosemide, and the combination in patients with chronic heart failure.
Goldsmith SR; Gilbertson DT; Mackedanz SA; Swan SK
J Card Fail; 2011 Dec; 17(12):982-9. PubMed ID: 22123359
[TBL] [Abstract][Full Text] [Related]
25. Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites.
Kalambokis G; Economou M; Fotopoulos A; Bokharhii JA; Katsaraki A; Tsianos EV
Nephrol Dial Transplant; 2005 Aug; 20(8):1623-9. PubMed ID: 15886218
[TBL] [Abstract][Full Text] [Related]
26. [Diuretic-resistant edema].
Shiikai T; Ideura T; Matsui N; Koshikawa S
Nihon Rinsho; 1974 Aug; 32(8):2619-28. PubMed ID: 4612208
[No Abstract] [Full Text] [Related]
27. Atrial natriuretic peptide, sodium retention, and proteinuria in nephrotic syndrome.
Plum J; Mirzaian Y; Grabensee B
Nephrol Dial Transplant; 1996 Jun; 11(6):1034-42. PubMed ID: 8671965
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of metolazone and furosemide in children with furosemide-resistant edema.
Arnold WC
Pediatrics; 1984 Nov; 74(5):872-5. PubMed ID: 6493882
[TBL] [Abstract][Full Text] [Related]
29. Current Perspectives in Management of Edema in Nephrotic Syndrome.
Meena J; Bagga A
Indian J Pediatr; 2020 Aug; 87(8):633-640. PubMed ID: 32232733
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure.
Chen HH; Redfield MM; Nordstrom LJ; Cataliotti A; Burnett JC
Am J Physiol Renal Physiol; 2003 May; 284(5):F1115-9. PubMed ID: 12676739
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the diuretic effect of furosemide mixed with human albumin or fresh frozen plasma for patients with hypoalbuminemia in the intensive care unit.
Hsu CW; Lin SL; Sun SF; Chu KA; Chung HM; Chang HW
J Nephrol; 2006; 19(5):621-7. PubMed ID: 17136691
[TBL] [Abstract][Full Text] [Related]
32. The comparison of the diuretic and natriuretic efficacy of continuous and bolus intravenous furosemide in patients with chronic kidney disease.
Sanjay S; Annigeri RA; Seshadri R; Rao BS; Prakash KC; Mani MK
Nephrology (Carlton); 2008 Jun; 13(3):247-50. PubMed ID: 18315706
[TBL] [Abstract][Full Text] [Related]
33. Effect of nonsteroidal anti-inflammatory agents and diuretics in nephrotic syndrome patients.
Kshirsagar NA; Shah BP; Paul T; Acharya VN; Sattur PB; Sheth UK
Indian J Med Res; 1979 Nov; 70():801-6. PubMed ID: 535977
[No Abstract] [Full Text] [Related]
34. The added-up albumin enhances the diuretic effect of furosemide in patients with hypoalbuminemic chronic kidney disease: a randomized controlled study.
Phakdeekitcharoen B; Boonyawat K
BMC Nephrol; 2012 Aug; 13():92. PubMed ID: 22931630
[TBL] [Abstract][Full Text] [Related]
35. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
[TBL] [Abstract][Full Text] [Related]
36. Renal failure with nephrotic syndrome: reversal with large doses of furosemide.
Sakemi T; Uchida M; Baba N; Nagano Y; Shimokama T; Watanabe T
Nihon Jinzo Gakkai Shi; 1991 Jan; 33(1):59-64. PubMed ID: 2038133
[TBL] [Abstract][Full Text] [Related]
37. Does albumin and furosemide therapy affect plasma volume in nephrotic children?
Bircan Z; Kervancioğlu M; Katar S; Vitrinel A
Pediatr Nephrol; 2001 Jun; 16(6):497-9. PubMed ID: 11420914
[TBL] [Abstract][Full Text] [Related]
38. Furosemide-albumin complexes in refractory nephrotic syndrome and chronic renal failure.
Mattana J; Patel A; Ilunga C; Singhal PC
Nephron; 1996; 73(1):122-3. PubMed ID: 8742982
[No Abstract] [Full Text] [Related]
39. Pharmacokinetics of furosemide urinary elimination by nephrotic children.
Prandota J
Pediatr Res; 1983 Feb; 17(2):141-7. PubMed ID: 6828331
[TBL] [Abstract][Full Text] [Related]
40. A multicenter, randomized, double-blind, placebo-controlled study of tolvaptan monotherapy compared to furosemide and the combination of tolvaptan and furosemide in patients with heart failure and systolic dysfunction.
Udelson JE; Bilsker M; Hauptman PJ; Sequeira R; Thomas I; O'Brien T; Zimmer C; Orlandi C; Konstam MA
J Card Fail; 2011 Dec; 17(12):973-81. PubMed ID: 22123358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
